Suchergebnisse - "Wimbury, David"

PubPharm (7)

1

Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy : insights from the NEFIGAN trial

enthalten in: Kidney international | 2024

von Wimbury, D. | Muto, M. | Bhachu, J. | +12

2

Relationship between immunoglobulin A1 lectin-binding specificities, mesangial C4d deposits and clinical phenotypes in immunoglobulin A nephropathy

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2022

von Medrano, A. | Muijsemberg, A. | Wimbury, D. | +7

3

Inhibition of the Lectin Pathway of the Complement System as a Novel Approach in the Management of IgA Vasculitis-Associated Nephritis

enthalten in: Nephron | 2020

von Selvaskandan, H. | Kay Cheung, C. | Dormer, J. | +4

4

β1,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells

enthalten in: Kidney international | 2017

von Molyneux, K. | Wimbury, D. | Pawluczyk, I. | +5

5

Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1

enthalten in: Journal of the American Society of Nephrology : JASN | 2017

von Gale, D. | Molyneux, K. | Wimbury, D. | +11

6

The Effect of Resistance Exercise on Inflammatory and Myogenic Markers in Patients with Chronic Kidney Disease

enthalten in: Frontiers in physiology | 2017

von Watson, E. | Viana, J. | Wimbury, D. | +4

7

Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1

enthalten in: Journal of the American Society of Nephrology | 2017

von Gale, D. | Molyneux, K. | Wimbury, D. | +11

1
[1]